Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


26.07.2021

2 Ann Neurol
1 Curr Alzheimer Res
2 J Alzheimers Dis
2 JAMA
1 Nat Rev Neurol
1 Neurobiol Aging
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. DAUTRICOURT S, de Flores R, Landeau B, Poisnel G, et al
    Longitudinal changes in hippocampal network connectivity in Alzheimer's disease.
    Ann Neurol. 2021 Jul 19. doi: 10.1002/ana.26168.
    PubMed         Abstract available

  2. MOGHAVEM N, Henderson VW, Greicius MD
    Medicare should not cover aducanumab as a treatment for Alzheimer's disease.
    Ann Neurol. 2021 Jul 19. doi: 10.1002/ana.26167.
    PubMed        


    Curr Alzheimer Res

  3. SEIBEL R, Schneider RH, Gottlieb MGV
    Effects of Spices (Saffron, Rosemary, Cinnamon, Turmeric and Ginger) in Alzheimer's Disease.
    Curr Alzheimer Res. 2021 Jul 16. pii: CAR-EPUB-116752.
    PubMed         Abstract available


    J Alzheimers Dis

  4. NARA PL, Sindelar D, Penn MS, Potempa J, et al
    Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 16. pii: JAD210448. doi: 10.3233/JAD-210448.
    PubMed         Abstract available

  5. ALEXOPOULOS P, Skondra M, Kontogianni E, Vratsista A, et al
    Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer's Disease in a Naturalistic Clinical Setting.
    J Alzheimers Dis. 2021 Jul 15. pii: JAD210477. doi: 10.3233/JAD-210477.
    PubMed         Abstract available


    JAMA

  6. RUBIN R
    Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered.
    JAMA. 2021 Jul 21. pii: 2782427. doi: 10.1001/jama.2021.11558.
    PubMed        

  7. SCHULMAN KA, Greicius MD, Richman B
    Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
    JAMA. 2021 Jul 19. pii: 2782333. doi: 10.1001/jama.2021.11768.
    PubMed        


    Nat Rev Neurol

  8. YU M, Sporns O, Saykin AJ
    The human connectome in Alzheimer disease - relationship to biomarkers and genetics.
    Nat Rev Neurol. 2021 Jul 20. pii: 10.1038/s41582-021-00529.
    PubMed         Abstract available


    Neurobiol Aging

  9. PFEIL J, Hoenig MC, Doering E, van Eimeren T, et al
    Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease.
    Neurobiol Aging. 2021;106:119-129.
    PubMed         Abstract available


    PLoS One

  10. LIBOWITZ MR, Wei K, Tran T, Chu K, et al
    Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study.
    PLoS One. 2021;16:e0254332.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: